Latest news

Zag Bio launches with $80M to reprogram the immune system against autoimmune diseases

Zag Bio launches with $80M to reprogram the immune system against autoimmune diseases

Joachim Eeckhout
Daily Snap - 28. October 2025

Daily Snap - 28. October 2025

Joachim Eeckhout
Hemab raises $157M to lead next wave in rare blood disorder treatments

Hemab raises $157M to lead next wave in rare blood disorder treatments

Joachim Eeckhout
Novartis buys Avidity for $12B to lead RNA drug push for muscle disease

Novartis buys Avidity for $12B to lead RNA drug push for muscle disease

Joachim Eeckhout
Daily Snap - 27. October 2025

Daily Snap - 27. October 2025

Joachim Eeckhout
Lilly acquires struggling Adverum in backloaded gene therapy deal

Lilly acquires struggling Adverum in backloaded gene therapy deal

Joachim Eeckhout
Biogen bets big on immune drug from Vanqua Bio in $1B+ deal

Biogen bets big on immune drug from Vanqua Bio in $1B+ deal

Joachim Eeckhout
Daily Snap - 23. October 2025

Daily Snap - 23. October 2025

Joachim Eeckhout
Flagship Pioneering launches $50M AI drug startup with Pfizer in tow

Flagship Pioneering launches $50M AI drug startup with Pfizer in tow

Joachim Eeckhout
Takeda strikes $11B oncology deal with Innovent to revive its pipeline

Takeda strikes $11B oncology deal with Innovent to revive its pipeline

Joachim Eeckhout
Daily Snap - 22. October 2025

Daily Snap - 22. October 2025

Joachim Eeckhout
GSK revives rejected antibiotic with phase 3 win for oral UTI treatment

GSK revives rejected antibiotic with phase 3 win for oral UTI treatment

Joachim Eeckhout
FirstBack
89101112131415
Next Last